Outcomes of upper tract urothelial cancer managed non-surgically

Jamil S. Syed, Kevin A. Nguyen, Alfie Suarez-Sariemento, Cynthia Leung, Marianne Casilla-Lennon, Jay D. Raman, Brian Shuch

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: Approximately 7% of patients with localized upper tract urothelial cancer (UTUC) are treated without definitive therapy. Understanding outcomes and alternative therapy would aid in counseling older patients with comorbidities. MATERIALS AND METHODS: We utilized the National Cancer Database to identify patients with localized UTUC managed non-surgically between 2004 and 2013. Patient demographics, comorbidity, tumor grade, and chemotherapy and radiation utilization were recorded. Survival analyses were performed with the Kaplan-Meier method and a cox proportional hazard regression model. RESULTS: We identified 3157 (10.9%) patients with localized UTUC who did not receive definitive surgery. Median age was 79 years, 55% were males, 79% had government health insurance, and 68% had a Charlson-Deyo Score (CDS) of 0. Tumor grade was low (grade 1 or 2) in 632 (36.4%) and high (grade 3 or 4) in 1104 (63.6%). Median overall survival (OS) for the cohort was 2.2 years, significantly shorter for patients with greater comorbidities. Chemotherapy or radiation was performed in 294 (9.3%) and 197 (6.3%) patients respectively. There were no OS differences for individuals receiving chemotherapy. Of patients who received radiation therapy, the median OS was 1.4 versus 2.0 years, (p < 0.001) favoring no radiation. Those with high grade tumors had worse survival (1.9 versus 3.8 years (p < 0.001). Significant predictors of shorter OS included older age, male gender, higher CDS, and government insurance. CONCLUSIONS: In this population-based cohort, 10.9% of patients with localized UTUC were managed non-surgically. There was no OS advantage noted in cohorts receiving chemotherapy and radiation therapy. Median OS was significantly shorter for those with higher grade disease, increasing comorbidity profile, male gender, and those with government insurance status.

Original languageEnglish (US)
Pages (from-to)9699-9707
Number of pages9
JournalThe Canadian journal of urology
Volume26
Issue number2
StatePublished - Apr 1 2019

Fingerprint

Survival
Neoplasms
Comorbidity
Drug Therapy
Radiation
Radiotherapy
Insurance Coverage
Health Insurance
Survival Analysis
Complementary Therapies
Insurance
Proportional Hazards Models
Individuality
Counseling
Demography
Databases
Population
Therapeutics

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Syed, J. S., Nguyen, K. A., Suarez-Sariemento, A., Leung, C., Casilla-Lennon, M., Raman, J. D., & Shuch, B. (2019). Outcomes of upper tract urothelial cancer managed non-surgically. The Canadian journal of urology, 26(2), 9699-9707.
Syed, Jamil S. ; Nguyen, Kevin A. ; Suarez-Sariemento, Alfie ; Leung, Cynthia ; Casilla-Lennon, Marianne ; Raman, Jay D. ; Shuch, Brian. / Outcomes of upper tract urothelial cancer managed non-surgically. In: The Canadian journal of urology. 2019 ; Vol. 26, No. 2. pp. 9699-9707.
@article{8eca177a465b435db0462fd80619388a,
title = "Outcomes of upper tract urothelial cancer managed non-surgically",
abstract = "INTRODUCTION: Approximately 7{\%} of patients with localized upper tract urothelial cancer (UTUC) are treated without definitive therapy. Understanding outcomes and alternative therapy would aid in counseling older patients with comorbidities. MATERIALS AND METHODS: We utilized the National Cancer Database to identify patients with localized UTUC managed non-surgically between 2004 and 2013. Patient demographics, comorbidity, tumor grade, and chemotherapy and radiation utilization were recorded. Survival analyses were performed with the Kaplan-Meier method and a cox proportional hazard regression model. RESULTS: We identified 3157 (10.9{\%}) patients with localized UTUC who did not receive definitive surgery. Median age was 79 years, 55{\%} were males, 79{\%} had government health insurance, and 68{\%} had a Charlson-Deyo Score (CDS) of 0. Tumor grade was low (grade 1 or 2) in 632 (36.4{\%}) and high (grade 3 or 4) in 1104 (63.6{\%}). Median overall survival (OS) for the cohort was 2.2 years, significantly shorter for patients with greater comorbidities. Chemotherapy or radiation was performed in 294 (9.3{\%}) and 197 (6.3{\%}) patients respectively. There were no OS differences for individuals receiving chemotherapy. Of patients who received radiation therapy, the median OS was 1.4 versus 2.0 years, (p < 0.001) favoring no radiation. Those with high grade tumors had worse survival (1.9 versus 3.8 years (p < 0.001). Significant predictors of shorter OS included older age, male gender, higher CDS, and government insurance. CONCLUSIONS: In this population-based cohort, 10.9{\%} of patients with localized UTUC were managed non-surgically. There was no OS advantage noted in cohorts receiving chemotherapy and radiation therapy. Median OS was significantly shorter for those with higher grade disease, increasing comorbidity profile, male gender, and those with government insurance status.",
author = "Syed, {Jamil S.} and Nguyen, {Kevin A.} and Alfie Suarez-Sariemento and Cynthia Leung and Marianne Casilla-Lennon and Raman, {Jay D.} and Brian Shuch",
year = "2019",
month = "4",
day = "1",
language = "English (US)",
volume = "26",
pages = "9699--9707",
journal = "Canadian Journal of Urology",
issn = "1195-9479",
publisher = "Canadian Journal of Urology",
number = "2",

}

Syed, JS, Nguyen, KA, Suarez-Sariemento, A, Leung, C, Casilla-Lennon, M, Raman, JD & Shuch, B 2019, 'Outcomes of upper tract urothelial cancer managed non-surgically', The Canadian journal of urology, vol. 26, no. 2, pp. 9699-9707.

Outcomes of upper tract urothelial cancer managed non-surgically. / Syed, Jamil S.; Nguyen, Kevin A.; Suarez-Sariemento, Alfie; Leung, Cynthia; Casilla-Lennon, Marianne; Raman, Jay D.; Shuch, Brian.

In: The Canadian journal of urology, Vol. 26, No. 2, 01.04.2019, p. 9699-9707.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Outcomes of upper tract urothelial cancer managed non-surgically

AU - Syed, Jamil S.

AU - Nguyen, Kevin A.

AU - Suarez-Sariemento, Alfie

AU - Leung, Cynthia

AU - Casilla-Lennon, Marianne

AU - Raman, Jay D.

AU - Shuch, Brian

PY - 2019/4/1

Y1 - 2019/4/1

N2 - INTRODUCTION: Approximately 7% of patients with localized upper tract urothelial cancer (UTUC) are treated without definitive therapy. Understanding outcomes and alternative therapy would aid in counseling older patients with comorbidities. MATERIALS AND METHODS: We utilized the National Cancer Database to identify patients with localized UTUC managed non-surgically between 2004 and 2013. Patient demographics, comorbidity, tumor grade, and chemotherapy and radiation utilization were recorded. Survival analyses were performed with the Kaplan-Meier method and a cox proportional hazard regression model. RESULTS: We identified 3157 (10.9%) patients with localized UTUC who did not receive definitive surgery. Median age was 79 years, 55% were males, 79% had government health insurance, and 68% had a Charlson-Deyo Score (CDS) of 0. Tumor grade was low (grade 1 or 2) in 632 (36.4%) and high (grade 3 or 4) in 1104 (63.6%). Median overall survival (OS) for the cohort was 2.2 years, significantly shorter for patients with greater comorbidities. Chemotherapy or radiation was performed in 294 (9.3%) and 197 (6.3%) patients respectively. There were no OS differences for individuals receiving chemotherapy. Of patients who received radiation therapy, the median OS was 1.4 versus 2.0 years, (p < 0.001) favoring no radiation. Those with high grade tumors had worse survival (1.9 versus 3.8 years (p < 0.001). Significant predictors of shorter OS included older age, male gender, higher CDS, and government insurance. CONCLUSIONS: In this population-based cohort, 10.9% of patients with localized UTUC were managed non-surgically. There was no OS advantage noted in cohorts receiving chemotherapy and radiation therapy. Median OS was significantly shorter for those with higher grade disease, increasing comorbidity profile, male gender, and those with government insurance status.

AB - INTRODUCTION: Approximately 7% of patients with localized upper tract urothelial cancer (UTUC) are treated without definitive therapy. Understanding outcomes and alternative therapy would aid in counseling older patients with comorbidities. MATERIALS AND METHODS: We utilized the National Cancer Database to identify patients with localized UTUC managed non-surgically between 2004 and 2013. Patient demographics, comorbidity, tumor grade, and chemotherapy and radiation utilization were recorded. Survival analyses were performed with the Kaplan-Meier method and a cox proportional hazard regression model. RESULTS: We identified 3157 (10.9%) patients with localized UTUC who did not receive definitive surgery. Median age was 79 years, 55% were males, 79% had government health insurance, and 68% had a Charlson-Deyo Score (CDS) of 0. Tumor grade was low (grade 1 or 2) in 632 (36.4%) and high (grade 3 or 4) in 1104 (63.6%). Median overall survival (OS) for the cohort was 2.2 years, significantly shorter for patients with greater comorbidities. Chemotherapy or radiation was performed in 294 (9.3%) and 197 (6.3%) patients respectively. There were no OS differences for individuals receiving chemotherapy. Of patients who received radiation therapy, the median OS was 1.4 versus 2.0 years, (p < 0.001) favoring no radiation. Those with high grade tumors had worse survival (1.9 versus 3.8 years (p < 0.001). Significant predictors of shorter OS included older age, male gender, higher CDS, and government insurance. CONCLUSIONS: In this population-based cohort, 10.9% of patients with localized UTUC were managed non-surgically. There was no OS advantage noted in cohorts receiving chemotherapy and radiation therapy. Median OS was significantly shorter for those with higher grade disease, increasing comorbidity profile, male gender, and those with government insurance status.

UR - http://www.scopus.com/inward/record.url?scp=85065116049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065116049&partnerID=8YFLogxK

M3 - Article

C2 - 31012833

AN - SCOPUS:85065116049

VL - 26

SP - 9699

EP - 9707

JO - Canadian Journal of Urology

JF - Canadian Journal of Urology

SN - 1195-9479

IS - 2

ER -

Syed JS, Nguyen KA, Suarez-Sariemento A, Leung C, Casilla-Lennon M, Raman JD et al. Outcomes of upper tract urothelial cancer managed non-surgically. The Canadian journal of urology. 2019 Apr 1;26(2):9699-9707.